Trials / Unknown
UnknownNCT02804204
Serum Biomarkers Analysis in Patients With AR Treated With Anti-TMF
Analysis of Circulant Rheumatoid Factor, Cyclic Citrullinated Anti-peptide Anti-bodies and Albumin as a Potential Predictor in the Response to the Treatment With Anti-TNF in Patients With Rheumatoid Arthritis
- Status
- Unknown
- Phase
- —
- Study type
- Observational
- Enrollment
- 200 (estimated)
- Sponsor
- Hospital Universitari Vall d'Hebron Research Institute · Academic / Other
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
Multicenter, prospective, observational study for evaluating if circulant rheumatoid factor, cyclic citrullinated anti-peptide anti-bodies and albumin can be used as potential predictors in the response to the treatment with anti-TNF in patients with rheumatoid arthritis after 24 weeks of treatment.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | Anti-TNF |
Timeline
- Start date
- 2016-06-01
- Primary completion
- 2019-12-01
- Completion
- 2019-12-01
- First posted
- 2016-06-17
- Last updated
- 2019-02-07
Locations
19 sites across 1 country: Spain
Source: ClinicalTrials.gov record NCT02804204. Inclusion in this directory is not an endorsement.